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ozenn N. Lemaitre, PHD, MPH,‡§ Gregory L. Burke, MD, MS,¶ David S. Siscovick, MD, MPH‡§
oston, Massachusetts; Seattle, Washington; and Winston-Salem, North Carolina
OBJECTIVES Our aim was to investigate the relation between fish consumption and incidence of congestive
heart failure (CHF).
BACKGROUND The incidence and health burden of CHF are rising, particularly in older persons. Although
n-3 fatty acids have effects that could favorably influence risk of CHF, the relation between
fish intake and CHF incidence is unknown.
METHODS Among 4,738 adults age 65 years and free of CHF at baseline in 1989–90, usual dietary
intake was assessed using a food frequency questionnaire. In a participant subsample,
consumption of tuna or other broiled or baked fish, but not fried fish, correlated with plasma
phospholipid n-3 fatty acids. Incidence of CHF was prospectively adjudicated.
RESULTS During 12 years’ follow-up, 955 participants developed CHF. In multivariate-adjusted
analyses, tuna/other fish consumption was inversely associated with incident CHF, with 20%
lower risk with intake 1 to 2 times/week (hazard ratio [HR]  0.80, 95% confidence interval
[CI]  0.64 to 0.99), 31% lower risk with intake 3 to 4 times/week (HR  0.69, 95% CI 
0.52 to 0.91), and 32% lower risk with intake 5 times/week (HR  0.68, 95% CI  0.45
to 1.03), compared with intake 1 time/month (p trend  0.009). In similar analyses, fried
fish consumption was positively associated with incident CHF (p trend  0.01). Dietary
long-chain n-3 fatty acid intake was also inversely associated with CHF (p trend  0.009),
with 37% lower risk in the highest quintile of intake (HR  0.73, 95% CI  0.57 to 0.94)
compared with the lowest.
CONCLUSIONS Among older adults, consumption of tuna or other broiled or baked fish, but not fried fish,
is associated with lower incidence of CHF. Confirmation in additional studies and evaluation
of potential mechanisms is warranted. (J Am Coll Cardiol 2005;45:2015–21) © 2005 by the
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.03.038American College of Cardiology Foundation
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eongestive heart failure (CHF) is a growing clinical and
ublic health problem. In the U.S., nearly 5 million indi-
iduals have CHF, more than 500,000 new cases are
iagnosed yearly, and CHF health care costs exceed $28
illion annually (1). Congestive heart failure is particularly
ommon with advancing age (2) and is the leading cause of
ospitalization among adults age 65 years (3). Among
lder adults, CHF incidence is 2% per year (4) and
redicts three to six times higher mortality (5). Identifica-
ion of measures for preventing CHF, particularly among
lder individuals, is therefore of considerable clinical and
ublic health importance.
In experimental studies, fish oil favorably affects hemo-
ynamics (6), inflammation (7), vascular responses (8–10),
nd left ventricular (LV) indices (11–17), each of which
ould reduce risk of CHF. In cross-sectional analyses (18),
1From the *Channing Laboratory, Department of Medicine, Brigham and Wom-
n’s Hospital and Harvard Medical School, and the Departments of Nutrition and
pidemiology, Harvard School of Public Health, Boston, Massachusetts; the †Vet-
rans Affairs Puget Sound Health Care System, ‡Cardiovascular Health Research
nit and Departments of §Medicine and Epidemiology, University of Washington,
eattle, Washington; and the ¶Department of Public Health Sciences, Wake Forest
niversity School of Medicine, Winston-Salem, North Carolina. Supported by
ontracts N01-HC-85079 through N01-HC-85086, N01-HC-35129, and N01-
C-15103, and a Mentored Clinical Scientist Award (Dr. Mozaffarian; K08-HL-
75628) from the National Heart, Lung, and Blood Institute, National Institutes of
ealth. For participating CHS investigators and institutions, see “About CHS-
rincipal Investigators and Study Sites” at http://chs-nhlbi.org. Abstract presented at
he American Heart Association Conference on Cardiovascular Disease Epidemiol-
gy and Prevention, San Francisco, California, March 2004.q
Manuscript received December 26, 2004; revised manuscript received March 8,
005, accepted March 10, 2005.ntake of tuna or other broiled or baked fish is inversely
ssociated with systolic blood pressure, C-reactive protein
evels, and carotid intimal medial thickness, whereas fried
sh intake is positively associated with systolic blood pres-
ure and carotid intimal medial thickness, all independent
isk factors for CHF (4). However, although the relation
etween fish intake and coronary heart disease risk has been
nvestigated (19), little is known regarding relation of fish
ntake, or indeed, any dietary factor, with incidence of CHF
n humans.
We investigated associations between fish consumption
nd incidence of CHF in the Cardiovascular Health Study,
population-based cohort study of determinants of cardio-
ascular disease among adults age 65 years. Our hypoth-
sis was that consumption of tuna and other broiled or
aked fish, but not fried fish, would be associated with a
ower incidence of CHF.
ETHODS
esign and population. In 1989 to 1990 and 1992, 5,888
en and women age 65 years were randomly selected and
nrolled from Medicare eligibility lists in four U.S. com-
unities (20,21). Baseline evaluation included health status,
edical history, physical examination, electrocardiography,
chocardiography, carotid ultrasonography, pulmonary
unction testing, and laboratory testing (2,4,5,20–22). We
xcluded 687 participants enrolled in 1992 (a food frequency
uestionnaire [FFQ] was not administered in 1992), 105
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Fish Intake and Incident Heart Failure June 21, 2005:2015–21articipants with incomplete data on fish consumption, and
58 participants with baseline CHF (22) or abnormal LV
jection fraction (45%) (5) (final n 4,738). Each center’s
nstitutional review committee approved the study, and all
ubjects gave informed consent.
ietary assessment. A picture-sort FFQ was administered
t baseline to assess usual dietary intake of tuna fish, other
sh (broiled or baked), and fried fish or fish sandwiches
fried fish burgers) (18,23). For each type, participants
eported their usual intake during the past year, with
esponse categories ranging from 4 times a year to 5
imes/week. For most nutrients, the midpoint of each
ategory was used to sum intakes of different items. On the
asis of detailed assessments of fish consumption performed
n a separate cohort (24) (D. Siscovick, personal communi-
ation, October 18, 2004), the median fish intakes for the
wo highest response categories were calculated to be
lightly less than the category midpoint; this had no effect
n the relative ranking of participants’ fish intakes or the
stimates of relative risk among participants, but likely
etter estimated the absolute fish intake for each participant.
e have shown that as a biomarker of fish oil content,
lasma phospholipid levels of eicosapentaenoic acid (EPA)
nd docosahexaenoic acid (DHA) correlate with intake of
una fish (Spearman correlation [r] 0.35, p 0.01), other
sh (r  0.59, p  0.001), and combined tuna/other fish (r
0.55, p  0.001), but not fried fish (r  0.04, p  0.78)
19). Dietary EPA  DHA was calculated from FFQ
esponses using estimates for each fish serving (3 to 5 oz)
25), including shellfish, and U.S. commercial landings data
26); this estimate correlated with plasma phospholipid
PA  DHA levels (r  0.52, p  0.001, n  65).
scertainment of CHF. Potential cases of CHF were
dentified from annual examinations, six-month phone con-
acts, and hospitalization discharge summaries. Incident
ases were centrally adjudicated using interviews, outpatient
ecords, discharge summaries, history and examination data,
nd review of relevant diagnostic tests and consultations
4,27). Confirmation of a diagnosis of CHF required each
f the following: 1) CHF symptoms (shortness of breath,
atigue, orthopnea, paroxysmal nocturnal dyspnea) and signs
edema, rales, tachycardia, gallop rhythm, displaced apical
mpulse) or clinical findings (such as on echocardiography,
ontrast ventriculography, or chest radiography); 2) diagno-
Abbreviations and Acronyms
CHF  congestive heart failure
CHS  Cardiovascular Health Study
CI  confidence interval
DHA docosahexaenoic acid
EPA  eicosapentaenoic acid
FFQ  food frequency questionnaire
HR  hazard ratio
LV  left ventricularis of CHF by a treating physician; and 3) medical therapy gor CHF (diuretics and either digitalis or a vasodilator
nitroglycerin, hydralazine, angiotensin-converting enzyme
nhibitor]).
nalysis. Kaplan-Meier methods were used to evaluate
HF-free survival. Risk was estimated using Cox propor-
ional hazards (time at risk until first event, death, or latest
ollow-up through June 30, 2001), with covariates based on
linical interest, associations with incident CHF (4), or
ssociations with exposures/outcomes in the present analy-
is. The final model included age; gender; race; enrollment
ite; education; diabetes; body mass index; prevalent coro-
ary heart disease; prevalent stroke/transient ischemic at-
ack; and intakes of tuna/other fish, fried fish, and total
alories. A second model was further adjusted for other
ehavioral and lifestyle factors including smoking; leisure-
ime physical activity; and intakes of saturated fat, fruits,
egetables, and alcohol. We also evaluated for potential
ediation or confounding by levels of systolic blood pres-
ure, diastolic blood pressure, baseline LV systolic function,
ow-density lipoprotein, high-density lipoprotein, triglycer-
des, and C-reactive protein. For parsimony in model
onstruction, we excluded from the final models other
ovariates that did not materially alter relations between fish
onsumption and CHF risk, including annual income;
reated hypertension; exercise intensity; forced expiratory
olume in 1 s; carotid intimal medial thickness; atrial
brillation; M-mode echocardiography-estimated LV mass;
se of aspirin, beta-blockers, lipid-lowering medication, fish
il, and estrogen; serum fasting glucose, insulin, creatinine,
nd fibrinogen; and estimated intakes of total fat, carbohy-
rates, protein, linolenic acid, fiber, beef/pork, wine, thia-
ine, and vitamin C. Missing covariate values (typically
1%) were imputed using age, race, gender, diabetes, and
revalent cardiovascular disease; analyses using population
edians or excluding missing data were not appreciably
ifferent. Tests for trend were evaluated with intake cate-
ories entered as ordinal variables. Potential effect modifi-
ation was assessed using stratified analyses and likelihood-
atio testing (exposure times covariate term). Analyses were
erformed using Stata 8.0 (D.M.) (Stata Corp., College
tation, Texas), with two-tailed alpha  0.05.
ESULTS
ean participant age was 73 years at baseline. Median fried
sh and tuna/other fish consumption were 0.5 and 1.0
ervings/week, respectively. Tuna/other fish consumption
as associated with younger age, female gender, higher
ducation, and generally a more favorable cardiovascular risk
rofile, although higher intake was also associated with
reater body mass index and higher low-density lipoprotein
holesterol (Table 1). Tuna/other fish consumption was
ositively associated with intakes of fruits, vegetables, alco-
ol, and total energy and inversely associated with saturated
at intake. Fried fish consumption was associated with male
ender, non-white race, lower education, a generally less
f
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June 21, 2005:2015–21 Fish Intake and Incident Heart Failureavorable cardiovascular risk profile, and higher intakes of
aturated fat, beef/pork, vegetables, and total energy. Asso-
iations of these fish meals with risk of CHF were therefore
valuated with and without adjustment for each of these
actors.
During 12 years of follow-up, 955 participants (20%)
eveloped incident CHF. Among individuals consuming
una/other fish 3 times/week, incidence of CHF was 19
er 1,000 person-years, compared with 30 per 1,000 person-
ears among individuals consuming tuna/other fish 1
ime/month (p  0.0001) (Fig. 1). Among persons con-
uming fried fish 1 time/week, incidence of CHF was 29
er 1,000 person-years, compared with 21 per 1,000 person-
ears among persons consuming fried fish 1 time/month
p  0.0001) (Fig. 1).
In age-adjusted analyses, tuna/other fish consumption
as inversely associated with risk of CHF (Table 2). After
ultivariate adjustment (Model 1), relative risks (hazards)
f CHF were 0.78 (95% CI  0.63 to 0.97), 0.68 (95% CI
0.53 to 0.88), and 0.65 (95% CI  0.44 to 0.97) for
una/other fish intake 1 to 2 times/week, 3 to 4 times/week,
nd 5 times/week, compared with 1 time/month (p
rend 0.003). Further adjustment for other behavioral and
ifestyle factors (Model 2) had only a small effect on these
isk estimates, indicating little evidence for additional con-
ounding by factors beyond those in Model 1. Notably,
able 1. Baseline Characteristics According to Fish Consumption
Frequency of Intake (n)
Tuna/Ot
<1/mo
(510)
1–3/mo
(1,095)
1–2
(2,2
ge, yrs 74.2 73.1 72
ender, % male 46 46 42
hite race, % 94 95 95
iabetes, % 24 22 22
oronary heart disease, % 17 15 16
ducation  high school, % 52 69 76
ody mass index, kg/m2 26.0 26.3 26
urrent smoker, % 16 14 11
reated hypertension, % 45 44 42
ystolic BP, mm Hg 138 136 136
eisure-time activity, kcal/wk 1,632 1,821 1,899
eft ventricular mass, g 151 153 151
orderline EF (45%–54%), % 7 6 5
DL cholesterol, mg/dl 126 127 131
DL cholesterol, mg/dl 52 53 55
-reactive protein, mg/dl 0.37 0.37 0
otal energy intake, kcal/day 1,633 1,608 1,846
aturated fat, % energy 13 12 12
lcohol, beverages/wk 1.5 2.5 2
eef/pork, servings/day 0.9 0.8 0
ruits, servings/day 1.7 1.8 2
egetables, servings/day 1.9 1.9 2
ietary EPA  DHA, mg/day‡ 19 83 261
alues are mean (continuous variables) or percent (categorical variables). *p  0.05
ategories of fried fish intake were combined with those consuming fried fish at least o
ata and estimated EPA  DHA content in each serving (3 to 5 oz) (26,27).
BP  blood pressure; DHA  docosahexaenoic acid; EF  left ventricular ejec
ow-density lipoprotein; mo  month; wk  week.ower risk was evident with modest intake (1 to 2 times/ seek). Further, the observed lower risk was similar for
ntakes of 3 to 4 times/week and 5 times/week (with
orderline significance in the latter category owing to less
erson-time and fewer numbers of events).
In contrast, fried fish consumption was positively associ-
ted with incidence of CHF (Table 2). In age-adjusted
nalyses, intake 1 time/week was associated with a 42%
igher risk (95% CI  21% to 67%), compared with intake
1 time/month. Adjustment for other risk factors (Model
) partly attenuated this higher risk, suggesting that it might
ave been partly related to differences in these factors.
owever, even after multivariate adjustments, there was
ittle evidence to suggest that fried fish intake might lower
he risk of CHF (Models 1 and 2).
We also evaluated the relation between dietary EPA 
HA and CHF risk. Because our focus was on diet, we
xcluded the few participants reporting fish oil supplement
se at baseline (n  181). After multivariate adjustment (as
n Model 2), EPA  DHA intake was inversely associated
ith risk of CHF (p trend  0.009) (Fig. 2). Compared
ith the lowest quintile of intake (92 mg/day), individuals
n the highest quintile (487 mg/day) had a 37% lower risk
f CHF (95% CI  6% to 43%).
We evaluated for potential mediation or confounding by
actors that fish intake might directly influence, including
ystolic blood pressure, diastolic blood pressure, baseline LV
ish Fried Fish
3–4/wk
(720)
5/wk
(203)
<1/mo
(2,307)
1–3/mo
(1,521)
>1/wk†
(910)
71.5 71.9 * 72.8 72.3 72.9
35 30 * 37 45 49 *
97 92 97 95 91 *
19 27 21 21 25 *
16 24 15 16 18 *
83 79 * 79 70 62 *
26.7 26.8 * 26.1 26.6 26.8 *
11 7 * 12 11 12
43 46 43 43 44
133 134 * 135 136 136
1,937 1,721 1,789 1,900 1,922
150 145 * 148 153 155 *
4 5 * 4 6 7 *
137 130 * 130 130 132
55 56 * 56 53 53 *
0.29 3.0 * 0.31 0.35 0.35
2,042 2,415 * 1,620 1,857 2,279 *
11 11 * 11 12 13 *
3.0 2.3 * 2.7 2.7 2.4
0.8 0.9 0.7 0.9 1.2 *
2.5 2.8 * 2.2 2.1 2.2
3.1 4.1 * 2.4 2.4 2.7 *
474 1,064 * 4 22 85 *
inal trend across categories of intake. †The few individuals (n  65) in the higher
er week. ‡Estimated intake from these fish meals based on U.S. commercial landings
raction; EPA  eicosapentaenoic acid; HDL  high-density lipoprotein; LDL her F
/wk
10)
.5
.4
.32
.9
.9
.2
.5
for ord
nce pystolic function (normal vs. borderline), low-density li-
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Fish Intake and Incident Heart Failure June 21, 2005:2015–21oprotein, high-density lipoprotein, triglycerides, and
-reactive protein. Adjustment for these factors slightly
ttenuated the relation between fish intake and incident
igure 1. Survival free of congestive heart failure (CHF) according to
una/other fish consumption and fried fish consumption (each adjusted for
he other).
able 2. Risk of Incident Congestive Heart Failure According to
Frequency of Intake <1/mo 1–3/mo
una/other fish
No. events 120 228
Person-years 4,051 9,751
HR (95% CI): age-adjusted 1.0 (referent) 0.83 (0.67–1.04)
Model 1* 1.0 (referent) 0.84 (0.67–1.05)
Model 2† 1.0 (referent) 0.84 (0.67–1.06)
ried fish
No. events 441 291
Person-years 21,227 13,936
HR (95% CI): age-adjusted 1.0 (referent) 1.06 (0.91–1.23)
Model 1* 1.0 (referent) 1.00 (0.86–1.17)
Model 2† 1.0 (referent) 1.02 (0.87–1.19)
Adjusted for age (years), gender (male/female), race (white/nonwhite), enrollment sit
ass index (kg/m2), prevalent coronary heart disease (yes/no), prevalent stroke/trans
r tuna/other fish (categories of intake). †Further adjusted for other behavioral and
kcal/day), and intakes of saturated fat (percent energy), fruits (servings/day), vegeta
ategories of fried fish intake were combined with those consuming fried fish one to two t
CI  confidence interval; HR  hazard ratio; mo  month; wk  week.HF, with relative risks of 0.83 (95% CI  0.67 to 1.03),
.72 (95% CI  0.55 to 0.95), and 0.73 (95% CI  0.48 to
.09) for tuna/other fish intake 1 to 2 times/week, 3 to 4
imes/week, and 5 times/week, compared with 1 time a
onth (p trend  0.03), and relative risks of 0.98 (95% CI
0.84 to 1.14) and 1.30 (95% CI  1.08 to 1.56) for fried
sh intake 1 to 3 times/month and 1 time/week, com-
ared with 1 time/month (p trend  0.02) (other covari-
tes as in Model 2).
We performed stratified analyses to further assess poten-
ial confounding or effect modification. There was little
vidence that findings varied according to age, gender,
ducation, income, diabetes, smoking, physical activity,
revalent cardiovascular disease, treated hypertension, or
ystolic blood pressure (p  0.05 for each interaction; other
djustments as in Model 1), although CIs were broader in
ach subgroup because of fewer events. For example, the
elative risk of incident CHF with tuna/other fish intake3
imes/week, compared with 1 time/month, was 0.70
mong never-smokers (95% CI  0.49 to 1.02), 0.71
mong former smokers (95% CI  0.47 to 1.07), and 0.58
Consumption
1–2/wk 3–4/wk >5/wk p Trend
441 131 35
20,319 6,930 1,878
79 (0.65–0.97) 0.74 (0.58–0.95) 0.75 (0.51–1.09) 0.02
78 (0.63–0.97) 0.68 (0.52–0.89) 0.65 (0.44–0.97) 0.003
80 (0.64–0.99) 0.69 (0.52–0.91) 0.68 (0.45–1.03) 0.009
223 ‡ ‡
7,765
42 (1.21–1.67) 0.001
31 (1.09–1.57) 0.01
35 (1.12–1.62) 0.005
sites), education (high school, high school, high school), diabetes (yes/no), body
chemic attack (yes/no), total caloric intake (kcal/day), and intake of either fried fish
le factors including smoking (never, former, current), leisure-time physical activity
ervings/day), and alcohol (drinks/wk). ‡The few individuals (n  65) in the higher
igure 2. Risk of incident congestive heart failure according to estimated
ntake of dietary long-chain n-3 fatty acids (eicosapentaenoic acid [EPA]
docosahexaenoic acid [DHA]). Risk estimates are shown for quintiles of
ntake, with the lowest quintile as the reference category, with multivariate
djustments as in Model 2, Table 2.Fish
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June 21, 2005:2015–21 Fish Intake and Incident Heart Failuremong current smokers (95% CI  0.28 to 1.24) (p
nteraction  0.82); 0.75 among individuals with less than
high school education (95% CI  0.47 to 1.19), 0.48
mong individuals with a high school education (95% CI 
.30 to 0.78), and 0.66 among individuals with more than a
igh school education (95% CI  0.43 to 1.02) (p interac-
ion  0.17); and 0.66 among individuals with an annual
ncome$35,000 (95% CI 0.34 to 1.30) and 0.72 among
ndividuals with an annual income $35,000 (95% CI 
.54 to 0.95) (p interaction  0.77). Effect modification by
sh oil supplementation could not be evaluated given the
ew individuals taking fish oil (n  181), but exclusion of
hese participants had little effect (data not shown). There
as little evidence for interaction between tuna/other fish
ntake and fried fish intake (p interaction  0.65).
We also assessed the extent to which the relation between
sh intake and CHF incidence might be related to associ-
tions between fish intake and nonfatal myocardial infarc-
ion (18) or atrial fibrillation (28). After adjustment for
revalent or incident myocardial infarction as a time-varying
ovariate (other adjustments as in Model 1), fish intake was
till associated with an incidence of CHF, with 26% lower
isk with tuna/other fish intake  times a week (HR 
.74, 95% CI  0.57 to 0.95) compared with 1 time/
onth, and 38% higher risk with fried fish intake 1
ime/week (HR  1.38, 95% CI  1.15 to 1.65), compared
ith 1 time/month. In similar analyses adjusting for
revalent or incident atrial fibrillation, fish intake was still
ssociated with incidence of CHF, with 34% lower risk with
una/other fish intake 3 times/week (HR  0.66, 95% CI
0.51 to 0.86) compared with 1 time/month, and 28%
igher risk with fried fish intake 1 time/week (HR 
.28, 95% CI  1.07 to 1.53) compared with 1 time/
onth.
ISCUSSION
mong these older adults, consumption of tuna or other
roiled or baked fish was associated with a lower incidence
f CHF, with 20% lower a risk with intake 1 to 2
imes/week and 30% lower risk with intake 3 times/
eek, compared with intake 1 time/month. Estimated
ntake of marine n-3 fatty acids was also associated with
ower CHF risk, with 37% lower risk in the highest quintile
f intake compared with the lowest.
ossible mechanisms: tuna/other fish. The inverse rela-
ion between tuna/other fish intake and CHF could be due
o other healthier lifestyle or socioeconomic characteristics
hat reduce CHF risk. We adjusted for education, smoking,
hysical activity, and various other clinical and behavioral
isk factors. Further, findings were similar in analyses
tratified by education, income, smoking, physical activity,
nd clinical characteristics and after adjustment for preced-
ng nonfatal myocardial infarction or atrial fibrillation.
evertheless, the possibility of residual confounding cannot
e excluded. FThere are plausible biologic mechanisms whereby tuna/
ther fish intake might reduce the incidence of CHF. In
xperimental studies, fish oil favorably affects hemodynamic,
ascular, and LV indices. In rats, fish oil intake reduces
eripheral vascular resistance (8), reduces myocardial oxygen
onsumption at given workloads (9), increases contractile
ecovery following ischemia-reperfusion (9), augments LV
esponse to exercise training (10), and reduces LV hyper-
rophy (11). In nonhuman primates, fish oil lowers resting
eart rate, increases LV ejection fraction, and improves
yocardial efficiency, possibly related to enhanced diastolic
lling (12,13). In humans, fish oil supplementation lowers
lood pressure (6), reduces markers of inflammation (7),
ttenuates vasoconstrictive responses to angiotensin II
14,15), improves arteriolar compliance (16), and improves
V diastolic filling (17). Each of these mechanisms could
ontribute to a beneficial effect of tuna/other fish intake on
he incidence of CHF.
Although these experimental effects were individually
emonstrated in humans in short-term trials of fish oil
upplementation (3 to 5 g/day), dietary doses (0.5 g/day)
ay result in more modest effects that over the long term
ombine to reduce CHF risk. In bivariate analyses, tuna/
ther fish intake correlated with plasma phospholipid EPA
DHA and was inversely associated with blood pressure,
-reactive protein, LV mass, and borderline systolic func-
ion at baseline. These associations were most pronounced,
nd CHF risk was lowest, among persons consuming
una/other fish at least 3 times/week, the equivalent of
500 mg/day EPA  DHA. Conversely, adjustment for
hese factors only partly attenuated the inverse association
etween tuna/other fish intake and CHF risk, suggesting
hat differences in these factors, based upon a single mea-
urement at baseline, do not completely mediate this asso-
iation.
If tuna/other fish intake reduces the incidence of CHF,
ffects could be mediated by influences on systolic function,
iastolic function, or both. Effects on diastolic function may
e particularly relevant in older persons, as nearly two-thirds
f older CHF patients have normal systolic function (2).
xperimentally observed effects of fish oil on peripheral
ascular resistance and LV diastolic filling (8,12–17) are
ntriguing, suggesting that fatty fish intake could reduce
iastolic heart failure. Further investigation of these effects
s warranted.
ossible mechanisms: fried fish. The association between
ried fish intake and CHF risk appeared partly related to
ssociations with higher risk clinical and lifestyle factors.
owever, the balance of benefit versus risk of these fish
eals may also be unfavorable. Although detailed informa-
ion on fish species or cooking oils was not available, the
ack of correlation with plasma phospholipid n-3 fatty acid
evels suggests that these fish meals were mostly lean (white)
sh; although frying adds other fatty acids from the frying
il, it does not reduce the absolute n-3 content (29,30).
rying may add oxidation products (30) or, with partially
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Fish Intake and Incident Heart Failure June 21, 2005:2015–21ydrogenated oils, transfatty acids, and frying may also have
dverse health effects when oils/fats are used repeatedly for
rying (31,32). Thus, if relatively little benefit is present
wing to low fish oil content, the net effect may be
etrimental. In bivariate analyses in this report, fried fish
ntake was positively associated with C-reactive protein, LV
ass, and borderline systolic function at baseline, each of
hich predict incident CHF (4). Further investigation is
ecessary to confirm these observations, determine if they
re specific for certain kinds of fish or frying oils, and
xamine potential mechanisms and alternative explanations.
lthough it would be premature to conclude that fried fish
ntake increases the risk of CHF, our findings indicate that
ntake of such fish meals is unlikely to reduce CHF risk.
trengths. The prospective cohort design reduces potential
ias from recall differences or control-selection bias. The
opulation-based recruitment strategy enhances generaliz-
bility. Standardized assessment of a variety of characteris-
ics increases the capacity to adjust for potential confound-
ng factors. Close follow-up, comprehensive review of
otential events, and centralized adjudication reduce the
otential for missed or misclassified outcomes.
tudy limitations. More detailed information on fish spe-
ies consumed or other preparation methods was not avail-
ble. Fish intake was assessed at baseline, and consumption
ay have changed over time; without bias, this would result
n underestimation of the relation between fish consump-
ion and CHF risk. Precise quantification of fish intake was
imited by the questionnaire response categories; however,
ndividuals reporting greater tuna/other fish consumption
ad higher plasma phospholipid EPA  DHA levels,
ndicating reasonably accurate qualitative ranking of fish
ntake. Standardized assessment of LV function was not
vailable in all participants at time of CHF diagnosis, so
ystolic versus diastolic heart failure could not be evaluated.
otential risks of fish intake for other health outcomes, such
s from mercury contamination (33), were not evaluated.
esidual confounding due to unknown or incompletely
easured characteristics could not be excluded. Associations
ere observed in older, predominantly white individuals
articipating in a cohort study and may not be generalizable
o other populations.
onclusions. Our findings indicate that consumption of
una and other broiled or baked fish, but not fried fish or
sh sandwiches, is associated with lower incidence of CHF
mong older adults. To our knowledge, this is the first study
o investigate associations between fish intake and risk of
HF, poised to become the leading cardiovascular health
urden in coming decades. Just as the notion that dietary
nfluences on coronary heart disease risk are principally
elated to saturated fat intake is a concept increasingly
utdated (34,35), the possibility that dietary habits have
mportant influences on other cardiovascular outcomes ap-
ears increasingly tenable. Confirmation of these findings in
ther studies and continued investigation of possible mech-nisms of benefit and risk, with attention to different types
f fish meals, is indicated.
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